LOS ANGELES - InstaCare Corp., a leading fulfillment provider of direct to patient diabetes programs, a leading provider of prescription drugs, home testing products for the chronically ill, and a leading developer of revolutionary cell phone centric e-health products and technologies, announced in a press release that on February 24, 2011, the Company filed a utility process Patent Application with the United States Patent and Trademark Office (USPTO) to secure its proprietary and unique MD@Hand and MD@Work technologies.

The patent is titled "HEALTHCARE INFORMATION MANAGEMENT AND COMMUNICATIONS SYSTEM AND METHOD." The Patent application  makes 104 separate claims. The company has received appropriate serial numbers from the USPTO recognizing the filing and the filing date.

With the filing of the full utility patent, the company plans to immediately engage and close several of its previously discussed strategic partnership arrangements with one or more major healthcare IT companies. These arrangements, when closed, are expected to have a material positive impact on the Company's revenue streams.

The Company also plans to file additional continuation in part patent applications covering (i) the Company's MD@Practice-Probe technologies; (ii) the Company's base communication technology for world-wide communication between cell phones and health data repositories and (iii) the Company's Medical Game Theory Methods and Processes specifically directed toward patient diagnosis and treatment protocols.

Robert Jagunich, Chairman of InstaCare Corp. commented, "After careful consultation with our intellectual property counsel, and after a recent favorable ruling from the US Supreme court (BILSKI ET AL. v. KAPPOS, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR, PATENT AND TRADEMARK OFFICE) we have now elected to file our full utility Patent covering 104 separate claims for our MD@Hand and MD@Work technologies. Both of these products make use of the company's proprietary securitized permanent EMR applications designed specifically for smart cell phones. The steps we have taken will protect the company and its shareholders from efforts initiated by our competition, patent trolls and copycats."

Keith Berman, CFO of InstaCare Corp. commented, "Our concept of offering medical legacy system applications that conform to the latest EMR/HER standards and that run on cell phones, support our seminal belief that our MD@Hand and MD@Work are game changing products.

Now that the healthcare market indecision is in the past, and with our full utility patent application on file, and additional continuation in part applications forthcoming, we will shortly publish a study completed in 2010 and recently updated, to provide our shareholders and the investment community with a third party evaluation of the potential economic value of our technologies. This study is a major part of our previously stated initiative to achieve a listing on the NYSE-Amex."